Thye Dirk is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Profile
Dirk Thye is the Chief Executive Officer (CEO) and Chief Medical Officer (CMO) of Quince Therapeutics, Inc., a preclinical biopharmaceutical company focused on bone-targeting drug platforms. According to the SEC filing with CIK 0001638945 dated 2026-01-24, he held both roles and had no reported stock purchases or sales. Quince Therapeutics is developing precision therapeutics for debilitating and rare diseases, including programs such as Ataxia-Telangiectasia (EryDex) and Duchenne-related approaches.
Role
Insider
Notability
40/100
Board memberships
Quince Therapeutics, Inc.
Awards & honors
CEO and CMO of Quince Therapeutics, Inc.
Leading a preclinical biopharmaceutical program focused on bone-targeting therapeutics
Frequently Asked Questions
Who is Thye Dirk?
Dirk Thye is the Chief Executive Officer (CEO) and Chief Medical Officer (CMO) of Quince Therapeutics, Inc., a preclinical biopharmaceutical company focused on bone-targeting drug platforms. According to the SEC filing with CIK 0001638945 dated 2026-01-24, he held both roles and had no reported stock purchases or sales. Quince Therapeutics is developing precision therapeutics f…
Where can I see all of Thye Dirk's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
